Alexey Kolyada
Overview
Explore the profile of Alexey Kolyada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kolyada A, Barrios D, Beglova N
Antibodies (Basel)
. 2017 Jul;
6(2).
PMID: 28748111
Upregulation of the procoagulant activity of monocytes by antibodies to beta2- glycoprotein I (β2GPI) is one of the mechanisms contributing to thrombosis in antiphospholipid syndrome. Current knowledge about receptors responsible...
2.
Kolyada A, Karageorgos I, Mahlawat P, Beglova N
FEBS J
. 2014 Dec;
282(5):864-73.
PMID: 25546421
β2 glycoprotein I (β2GPI) is the most common antigen for autoimmune antibodies in antiphospholipid syndrome (APS). Thrombosis is a clinical feature of APS. We created a molecule (A1-A1) that consists...
3.
Kolyada A, Porter A, Beglova N
Blood
. 2013 Nov;
123(7):1090-7.
PMID: 24277078
Antiphospholipid syndrome (APS) is an autoimmune disorder with increased risk for thrombosis and pregnancy losses. β2-glycoprotein I (β2GPI) is the major antigen for clinically relevant antibodies in APS. We engineered...
4.
Kolyada A, De Biasio A, Beglova N
Biochim Biophys Acta
. 2013 Jul;
1834(10):2080-8.
PMID: 23811002
Antiphospholipid syndrome (APS) is an autoimmune disease with clinical manifestations of thrombosis and pregnancy complications. Beta2-glycoprotein I (β2GPI) is the major antigen for the APS-related antibodies. Heparin, low-molecular weight heparin...
5.
Kolyada A, Lee C, De Biasio A, Beglova N
PLoS One
. 2010 Dec;
5(12):e15345.
PMID: 21179511
Background: β2GPI is a major antigen for autoantibodies associated with antiphospholipid syndrome (APS), an autoimmune disease characterized by thrombosis and recurrent pregnancy loss. Only the dimeric form of β2GPI generated...
6.
Wald R, Liangos O, Perianayagam M, Kolyada A, Herget-Rosenthal S, Mazer C, et al.
Clin J Am Soc Nephrol
. 2010 Jun;
5(8):1373-9.
PMID: 20522534
Background And Objectives: Little is known about the performance of plasma cystatin C (CysC) in patients undergoing cardiopulmonary bypass (CPB) and its utility in the early diagnosis of acute kidney...
7.
Liangos O, Kolyada A, Tighiouart H, Perianayagam M, Wald R, Jaber B
Nephron Clin Pract
. 2009 Aug;
113(3):c148-54.
PMID: 19672112
Background: Cardiopulmonary bypass (CPB) elicits an inflammatory response mediated partly by neutrophils, which are activated and recruited by interleukin-8 (IL-8). We hypothesized that acute kidney injury (AKI) following CPB might...
8.
Liangos O, Tighiouart H, Perianayagam M, Kolyada A, Han W, Wald R, et al.
Biomarkers
. 2009 Jul;
14(6):423-31.
PMID: 19572801
The purpose of this study was to compare the performance of six candidate urinary biomarkers, kidney injury molecule (KIM)-1, N-acetyl-beta-D-glucosaminidase (NAG), neutrophil gelatinase-associated lipocalin (NGAL), interleukin (IL)-18, cystatin C and...